MenB-FHbp Meningococcal Group B Vaccine (Trumenba(®)): A Review in Active Immunization in Individuals Aged ≥ 10 Years.

Shirley M, Taha MK

Open source

DOI
10.1007/s40265-018-0869-7
Published
2018 Feb
Container
Drugs
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40265-018-0869-7,
  title = {MenB-FHbp Meningococcal Group B Vaccine (Trumenba(®)): A Review in Active Immunization in Individuals Aged ≥ 10 Years.},
  author = {Shirley M and Taha MK},
  year = {2018},
  journal = {Drugs},
  doi = {10.1007/s40265-018-0869-7},
  url = {https://doi.org/10.1007/s40265-018-0869-7}
}

RIS

TY  - JOUR
TI  - MenB-FHbp Meningococcal Group B Vaccine (Trumenba(®)): A Review in Active Immunization in Individuals Aged ≥ 10 Years.
AU  - Shirley M
AU  - Taha MK
PY  - 2018
JO  - Drugs
DO  - 10.1007/s40265-018-0869-7
UR  - https://doi.org/10.1007/s40265-018-0869-7
ER  - 

APA

M, S., & MK, T. (2018). MenB-FHbp Meningococcal Group B Vaccine (Trumenba(®)): A Review in Active Immunization in Individuals Aged ≥ 10 Years.. Drugs. https://doi.org/10.1007/s40265-018-0869-7

Source records